MarketVIEW: Candida vaccines

$ 7 995 - July 2012 - by VacZine Analytics Group Of Assay Advantage Ltd - 50

Summary

Table of Contents

View Report

Search Inside

Data Series

Industry

Drug and Medication

Country

United Kingdom
United States
Oceania
Japan
Germany
France
Italy
Spain
Canada
Australia
World
Europe

Keywords

Drug
Vaccine

Candida yeasts cause Candidiasis which is a fungal infection commonly found in humans. Infections can occur in the female Genital area "vulvovaginal candidiasis" of which nearly 75% of all adult women have had one "yeast infection" in their lifetime. Some women experience recurrent episodes (RVVC) which can cause considerable inconvenience and distress. Invasive Candidiasis, is a life threatening infection which mainly affects individuals with serious underlying co-morbidities. Infections usually occur in the hospital intensive care unit (ICU) where it is the fourth most common bloodstream infection (CDC Figures).

This MarketVIEW This MarketVIEW product is a comprehensive MS Excel-based model + summary presentation which forecasts the potential commercial value of Candida vaccines across major Western markets until 2030. The model contains value ($ m) and volume (mio doses) predictions along with launch timeframe, pricing and penetration estimates for both Recurrent Vulvovaginal Candidiasis (RVVC) and invasive Candidiasis (in the ICU setting) indications. For RVVC indication 3 prevalence scenarios (LO/MID/HI) are included. The product also includes an up-to-date review of latest competitor activity in the field and Candida epidemiology.

THIS PRODUCT IS A SUMMARY PRESENTATION + MODEL

Executive Summary
RVVC TX vaccine: available market ($000s) to 2030, realistic RVVC
prevalence
RVVC TX vaccine: available market ($000s) to 2030 by conservative,
realistic and optimistic RVVC prevalence
RVVC TX vaccine: available market (000s doses) to 2030
Candida ICU PX vaccine: available market ($000s) to 2030
Candida ICU PX vaccine: available market (000s doses) to 2030
The role of Candida vaccines
Candida ICU PX vaccine: target product profile
RVVC TX vaccine: target product profile
Candida ICU PX vaccine: model assumptions
RVVC TX vaccine: model assumptions
Key commercial model assumptions
Pricing
Competitor landscape: overview
Pevion (PEV7)
NovaDigm Therapeutics (NDV-3)
Vulvovaginal candidiasis: overview
Vulvovaginal candidiasis: surveillance
Vulvovaginal candidiasis: regional data
Vulvovaginal candidiasis: primary care consultations
Vulvovaginal candidiasis: drug utilization
Vulvovaginal candidiasis: drug utilization
Vulvovaginal candidiasis: population based studies
Vulvovaginal candidiasis: incidence/prevalence summary
Invasive candidiasis: overview
Invasive candidiasis: national surveillance data
Invasive candidiasis: estimating ICU admissions
Bibliography
Disclaimer
About VacZine Analytics
PAGES: 50 MS PowerPoint slides, fully referenced/sourced. Available in .pdf form

Contents – Vaccine demand model (MS Excel-based)
Title
Scenarios
Charts value (RVVC)
Charts value (ICU)
Charts volume (RVVC and ICU)
Value summary (ICU)
Volume summary (ICU)
Value summary (RVVC)
Volume summary (RVVC)
Model inputs (RVVC)
ICU patients =>
US (ICU)
UK (ICU)
CANADA (ICU)
GERMANY (ICU)
SPAIN (ICU)
FRANCE (ICU)
ITALY (ICU)
EU other (ICU)
AUSTRALIA (ICU)
JAPAN (ICU)
RVVC patients =>
LO/BASE/HI prevalence scenarios
US (RVVC)
UK (RVVC)
CANADA (RVVC)
GERMANY (RVVC)
SPAIN (RVVC)
FRANCE (RVVC)
ITALY (RVVC)
EU other (RVVC)
AUSTRALIA (RVVC)
JAPAN (RVVC)
Source material ?
ICU database
RVVC database
UK RVVC epi
US ICU epi
Back page
Worksheets = >60 interconnected

Vaccine in United Kingdom

United Kingdom Vaccine Exports, Us$mn, % Y-o-y

$ 250
Industry data
January 2013

Yearly, From 2003 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Drug and Medication
Countries : United Kingdom

United Kingdom Vaccine Exports, Gbpmn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Drug and Medication
Countries : United Kingdom

United Kingdom Vaccine Exports, Gbpmn, % Y-o-y

$ 250
Industry data
January 2013

Yearly, From 2003 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Drug and Medication
Countries : United Kingdom

United Kingdom Vaccine Imports, Us$mn, % Y-o-y

$ 250
Industry data
January 2013

Yearly, From 2003 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Drug and Medication
Countries : United Kingdom

United Kingdom Vaccine Imports, Gbpmn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

Industries : Drug and Medication
Countries : United Kingdom

Drug and Medication in United Kingdom

United Kingdom Pharmaceutical Sales, Us$bn

$ 250
Industry data
January 2013

Yearly, From 2002 To 2021
By Business Monitor International
Source: IMS Health, Association of European Self-Medication Industry (AESGP), Department of Health, BMI

Industries : Drug and Medication
Countries : United Kingdom

United Kingdom Pharmaceutical Sales, Us$bn, % Chg Y-o-y

$ 250
Industry data
January 2013

Yearly, From 2003 To 2021
By Business Monitor International
Source: IMS Health, Association of European Self-Medication Industry (AESGP), Department of Health, BMI

Industries : Drug and Medication
Countries : United Kingdom

United Kingdom Pharmaceutical Sales, Gbpbn

$ 250
Industry data
January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: IMS Health, Association of European Self-Medication Industry (AESGP), Department of Health, BMI

Industries : Drug and Medication
Countries : United Kingdom

United Kingdom Pharmaceutical Sales, Gbpbn, % Chg Y-o-y

$ 250
Industry data
January 2013

Yearly, From 2005 To 2021
By Business Monitor International
Source: IMS Health, Association of European Self-Medication Industry (AESGP), Department of Health, BMI

Industries : Drug and Medication
Countries : United Kingdom

United Kingdom Pharmaceutical Sales At Constant Exchange Rate, Us$bn

$ 250
Industry data
January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: IMS Health, Association of European Self-Medication Industry (AESGP), Department of Health, BMI

Industries : Drug and Medication
Countries : United Kingdom

BUY THIS REPORT

ASK INFO SPECIALIST 24/7

Robyn - online now

00 1 718 213 49 04

Send Message @Robyn

Drug And Medication Industry in the United Kingdom : Latest Reports

Vaccines - Global Markets Package

$ 24 060
Industry report
May 2013
by Global Research & Data Services

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different countries around the world. The studies provide essential market ...

Infertility Drugs And Devices Market - Global Industry Analysis, Size, Share And Forecast, 2010 - 2017

$ 4 395
Industry report
November 2013
by Transparency Market Research

This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis ...

Triple Analysis: Angiogenesis, Cancer Vaccines and Peptides

$ 5 175
Industry report
March 2013
by Bioseeker

This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines and by the compound strategy of Peptides. Each of these three ...

Triple Analysis: Angiogenesis, Cancer Vacc ...

March 2013 $ 5 175

Triple Analysis: Angiogenesis, Cancer Vacc ...

March 2013 $ 5 175

Triple Analysis: Apoptosis, Angiogenesis A ...

March 2013 $ 5 175

Triple Analysis: Apoptosis, Cancer Vaccine ...

March 2013 $ 5 175

Triple Analysis: Apoptosis, Cancer Vaccine ...

March 2013 $ 5 175

Triple Analysis: Apoptosis, Cancer Vaccine ...

March 2013 $ 5 175

Triple Analysis: Breast Cancer, Angiogenes ...

March 2013 $ 5 175

More Reports:

Drug and Medication in China (129)

Drug and Medication in France (47)

Drug and Medication in Germany (47)

Drug and Medication in Italy (45)

Drug and Medication in Japan (60)

Drug and Medication in Spain (42)

Drug and Me... in the United Kingdom (48)

Drug and Me... in the United States (151)

Company Reports

GlaxoSmithKline P.L.C.

Novartis Inc.

Pfizer Inc.

Johnson And Johnson

GlaxoSmithKline PLC

Eli Lilly And Co.

AstraZeneca PLC

Lilly And Co.

Sanofi-Aventis Senegal

Bristol-Myers Squibb Co.

Drug And Medication Industry in the United Kingdom : Latest Downloads

Drug and Medication Industry Analysis

Industry report
April 2013
53 pages

... Use internally as part of a monthly cleansing regimen for gi health antibiotic, anti-inflammatory, antibacterial, antifungal, antioxidant, anti-parasitic, antiviral, disinfectant candida cleanse ...

Drug and Medication Market Brief

Industry report
April 2013
18 pages

... Antiosteoporosic drugs - casula m, filippi a, flacco e, gambera m, manzoli l, menditto e, orlando v, piccinelli r, tragni e, catapano a. Assessment and potential determinats of compliance and persistence to anti ...

Drug and Medication : Innovation and Technology Trends

Industry report
April 2013
12 pages

... Clinical regulatory toxicology phase i clinical phase ii clinical diabetes inflammation oncology (non-cytotoxic) anti-infectives clotting disorders obesity cns nce pipeline nce pipeline tyrosine-tzd, non ...

More Reports:

Drug and Medication in Australia (22)

Drug and Medication in Canada (46)

Drug and Medication in China (32)

Drug and Medication in India (99)

Related Market Segments :

Vaccine

Drug

Country Reports

United Kingdom

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.